MYP_097017
Basic Information
Vif (30-65)
Antimicrobial
Antiviral
Enzyme modulation Enzyme inhibition Protease inhibition
Standard
36 amino acids
C193H286N58O50
Standard
Sequence
YVSGKARGWFYRHHYESPHPRISSEVHIPLGDARLV
Physicochemical Analysis
4218.69 Da
9.52
2.11
1.70
0.0587
-0.66
0.38
-0.07
65.02
73.06
0.1389
9970.00
9970.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
1713.09
-14.00
62.0
56.0
129.0
301.0
13.0
35.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0021340 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral
HIV-1[20-30% PR activity = 1 microM
RECORD: Rec_0065235 VERIFIED: YES
Provenance & Taxonomy
Human immunodeficiency virus 1 [Virus]
11676
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral Protease inhibition
Hut-78
75 %
Inhibition
RECORD: Rec_0077053 VERIFIED: YES
Provenance & Taxonomy
not reported [other]
Structure & Mods
linear peptide; DSSP H 11.1%, E 33.3%, T 36.1%, C 19.4% [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Antimicrobial
RECORD: Rec_0111768 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral
Rous sarcoma virus[80-90% PR activity = 1 microM
RECORD: Rec_0300269 VERIFIED: YES
Provenance & Taxonomy
Human immunodeficiency virus 1 [Virus]
11676
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral Protease inhibition
75.1 %
Inhibition